Topic: MS

Disease-modifying therapies: long-term results

September 12, 2014  

Cognitive dysfunction in pediatric- vs. adult-onset MS

September 11, 2014  

Spinal taps prognostic in CIS

September 11, 2014  

Trend to earlier, more aggressive therapy: U.S. survey

September 11, 2014  

Atacicept: the aftermath

September 3, 2014  

New dosing for glatiramer acetate

August 6, 2014  

MS patient website tops 70,000 visits

June 3, 2014  

The time course of MS – AudioSlide presentation

May 28, 2014  

Alemtuzumab receives Health Canada approval

April 23, 2014  

MS treatment failure: who is at risk?

March 19, 2014